JGUA
IBB icon

John G. Ullman & Associates’s iShares Biotechnology ETF IBB Stock Holding History

John G. Ullman & Associates’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$323K Hold
1,700
– – 0.04% 156
2026
Q1 		$287K Hold
1,700
– – 0.04% 154
2025
Q4 		$287K Hold
1,700
– – 0.04% 157
2025
Q3 		$245K Hold
1,700
– – 0.03% 157
2025
Q2 		$215K Sell
1,700
-100
-6% -$12.3K 0.03% 162
2025
Q1 		$230K Buy
+1,800
New +$244K 0.04% 162
2024
Q4 		– Sell
-1,500
Closed -$218K – 180
2024
Q3 		$218K Sell
1,500
-100
-6% -$14.5K 0.03% 174
2024
Q2 		$220K Sell
1,600
-100
-6% -$13.3K 0.03% 168
2024
Q1 		$233K Hold
1,700
– – 0.04% 160
2023
Q4 		$231K Sell
1,700
-1,050
-38% -$128K 0.04% 153
2023
Q3 		$336K Sell
2,750
-50
-2% -$6.36K 0.06% 141
2023
Q2 		$355K Hold
2,800
– – 0.05% 142
2023
Q1 		$362K Hold
2,800
– – 0.06% 144
2022
Q4 		$368K Buy
+2,800
New +$362K 0.06% 137
2022
Q2 		– Sell
-1,700
Closed -$222K – 165
2022
Q1 		$222K Hold
1,700
– – 0.03% 161
2021
Q4 		$259K Sell
1,700
-300
-15% -$46.4K 0.04% 150
2021
Q3 		$323K Sell
2,000
-100
-5% -$16.8K 0.04% 137
2021
Q2 		$344K Hold
2,100
– – 0.04% 132
2021
Q1 		$316K Sell
2,100
-1,000
-32% -$159K 0.04% 131
2020
Q4 		$470K Hold
3,100
– – 0.07% 107
2020
Q3 		$420K Hold
3,100
– – 0.09% 88
2020
Q2 		$424K Hold
3,100
– – 0.1% 76
2020
Q1 		$334K Hold
3,100
– – 0.09% 84
2019
Q4 		$374K Buy
3,100
+200
+7% +$22.3K 0.06% 117
2019
Q3 		$289K Buy
+2,900
New +$304K 0.05% 120

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

John G. Ullman & Associates's IBB Position: Q2 2026 in Review

John G. Ullman & Associates held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 1,700 shares worth $323K. The position accounts for 0.04% of the portfolio, ranked #156.

John G. Ullman & Associates first reported a position in IBB in Q3 2019 and has held it in 25 quarters since. The position peaked at $470K in Q4 2020. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • John G. Ullman & Associates held 1,700 shares of iShares Biotechnology ETF worth $323K as of Q2 2026.
  • John G. Ullman & Associates left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.04% of John G. Ullman & Associates's portfolio in Q2 2026, its #156 holding.
  • John G. Ullman & Associates first reported a position in iShares Biotechnology ETF in Q3 2019 and has held it in 25 quarters since.
  • John G. Ullman & Associates's iShares Biotechnology ETF position peaked at $470K in Q4 2020.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on John G. Ullman & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.